President, Chief Executive Officer, and Member of the Board of Directors
Chief Human Resources Officer
Chief Financial Officer
Chief Technology Officer
Executive Vice President and Chief Medical Officer
Senior Vice President, Operations
The information provided by the HeartFlow Analysis is intended to be used in conjunction with the patient’s clinical history, symptoms, and other diagnostic tests, as well as the clinician’s professional judgement. The HeartFlow Analysis may not be appropriate for all patients. See indications for use for more information. The HeartFlow Analysis, featuring the FFRCT Analysis, RoadMapTM Analysis, Plaque Analysis, and HeartFlow Planner, has received FDA Clearance in the United States of America. The FFRCT Analysis and HeartFlow Planner are CE Marked in Europe and the United Kingdom and approved in Japan and Canada. The HeartFlow Analysis, featuring FFRCT Analysis, RoadMapTM Analysis, Plaque Analysis, and HeartFlow Planner, is commercially available in the United States. The FFRCT Analysis and HeartFlow Planner are commercially available in the United Kingdom. The FFRCT Analysis is also commercially available in Europe, Japan, and Canada.
© 2024 HeartFlow, Inc. | HeartFlow and the HeartFlow logo are registered trademarks of HeartFlow, Inc. Additionally, RoadMap is claimed as a trademark of HeartFlow, Inc. www.heartflow.com | 331 E Evelyn Ave, Mountain View, CA 94041
President, Chief Executive Officer, and Member of the Board of Directors
John brings more than 20 years of experience providing strategic oversight to deliver operational excellence and outstanding performance. Most recently, John served as Vice President and General Manager of the Aortic business at Medtronic. He also served in key leadership roles for Medtronic’s Cardiovascular and Diabetes Groups, including Vice President of the Americas region for the Insulin Pump and Continuous Glucose Monitoring business unit and Vice President for Asia Pacific.
John earned his BA from Duke University and his MBA from Northwestern’s Kellogg School of Management.
Chief Human Resources Officer
Stephanie has held HR leadership positions among some of the world’s leading organizations, including Edwards Lifesciences, Johnson and Johnson, Hologic, and Allergan. Most recently, she has spent time at Hugel Aesthetics, a growth-focused multinational organization where she was instrumental in growing the business more than 400% in less than two years.
Stephanie received her undergraduate degree from California State Polytechnic University, Pomona, and holds an MBA from Walden University.
Chief Financial Officer
Vikram spent more than 13 years in roles of increasing responsibility across strategy, business development, global marketing, regulatory affairs, and clinical affairs. Most recently, Vikram worked at Verily Life Sciences, where he was the Business Development lead for the medical device portfolio, and Medtronic, where he spent many years leading upstream marketing, business development and strategy.
Vikram has an MBA from The Wharton School of the University of Pennsylvania and a Master’s degree in biomedical engineering from the University of Southern California. He is also a CFA Charterholder.
Chief Technology Officer
Tim has 18 years of experience leading the development and market introduction of innovative healthcare technologies. He joined HeartFlow in 2010 and held various product, technology, and commercial leadership roles to build HeartFlow’s product and service. Previously, Tim led design engineering at Cameron Health (acquired by Boston Scientific) to bring the world’s first S-ICD from development to clinical use. He co-founded a company to develop custom-fit healthcare products and was a researcher in blood flow modeling from medical image data at Stanford. Tim holds over 140 patents and peer reviewed publications.
He received a B.S in engineering from Rensselaer Polytechnic Institute and M.S. in engineering from Stanford.
Executive Vice President and Chief Medical Officer
Campbell brings a wealth of experience to HeartFlow, where he serves as the Chief Medical Officer. Prior to joining HeartFlow, he was the Chief Scientific Officer and Global Head of Research and Development at Cordis Corporation, Johnson & Johnson, where he was responsible for leading investments and research in cardiovascular devices. Prior to Cordis, he was Associate Professor of Medicine at Harvard Medical School and the Harvard-M.I.T. Division of Health Sciences and Technology, and Director of the Cardiac Catheterization and Experimental Cardiovascular Interventional Laboratories at Brigham and Women’s Hospital. He served as Principal Investigator for numerous interventional cardiology device, diagnostic, and pharmacology trials, is the author of numerous journal articles, chapters, and books in the area of coronary artery and other cardiovascular diseases, and was the recipient of research grant awards from the NIH and AHA.
He received his A.B. from Harvard College and his M.D. from Harvard Medical School.
Senior Vice President, Operations
Kathleen is an accomplished Inside Sales and Customer Care executive with more than 15 years of experience. Her expertise spans driving process improvement and operational excellence, utilizing metrics/analytics to deliver results, and leading organizations through large-scale expansion. Most recently, Kathleen was Senior Director, Inside Sales Initiatives at Alto Pharmacy, a telehealth pharmacy startup. She has held operational leadership roles of increasing responsibility at Cardinal Health, Medtronic, W.W. Grainger and Deloitte Consulting.
Kathleen received undergraduate degrees from the University of Illinois and an MBA from The Wharton School at the University of Pennsylvania.
*Required fields
If you would like to request to have the HeartFlow Analysis available at a location near you, please submit your information below with details of the institution. We will share this information with the institution, but it will not guarantee HeartFlow will become available.
*Required fields
オンライン提出フォームから研究助成金を申請してください。
HeartFlow FFRCT 分析は、有資格の臨床医による臨床的に安定した症状のある冠状動脈疾患患者への使用を目的とした個別化された心臓検査です。 HeartFlow Analysis によって提供される情報は、資格のある臨床医が患者の病歴、症状、その他の診断検査、および臨床医の専門的判断と組み合わせて使用することを目的としています。
ハートフロー分析に関する追加の適応情報については、次のサイトをご覧ください。www.heartflow.com/indications.
さらに質問がある場合は、このメッセージを閉じてフォームに記入するか、サポート チームにお電話ください。: 877.478.3569.
The HeartFlow FFRCT Analysis is a personalized cardiac test indicated for use in clinically stable symptomatic patients with coronary artery disease by qualified clinicians. The information provided by the HeartFlow Analysis is intended to be used by qualified clinicians in conjunction with the patient’s history, symptoms, and other diagnostic tests, as well as the clinician’s professional judgement.
For additional indication information about the HeartFlow Analysis, please visit www.heartflow.com/indications.
If you have additional questions, close out of this message to complete our form or call our support team: 877.478.3569.Please use our online submission form on the Clinical Research Page to apply for research grants.
Thank you for your interest!